Compile Data Set for Download or QSAR
Report error Found 76 Enz. Inhib. hit(s) with all data for entry = 10315
TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527568(US11186588, Example 26)
Affinity DataIC50: 12.3nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527554(US11186588, Example 9)
Affinity DataIC50: 17.6nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527550(US11186588, Example 5)
Affinity DataIC50: 27.5nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527563(US11186588, Example 22 | US11186588, Example 21)
Affinity DataIC50: 30.3nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527557(US11186588, Example 12)
Affinity DataIC50: 32.1nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527563(US11186588, Example 22 | US11186588, Example 21)
Affinity DataIC50: 33.6nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527616(US11186588, Example 92)
Affinity DataIC50: 34.2nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527608(US11186588, Example 81)
Affinity DataIC50: 47.2nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527567(US11186588, Example 25)
Affinity DataIC50: 50.3nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527549(US11186588, Example 3)
Affinity DataIC50: 51.9nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527560(US11186588, Example 16)
Affinity DataIC50: 77.5nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527551(US11186588, Example 6)
Affinity DataIC50: 86.4nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527572(US11186588, Example 33)
Affinity DataIC50: 87.2nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527610(US11186588, Example 86 | US11186588, Example 83)
Affinity DataIC50: 95.3nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527617(N-(4-(2,3,9-trimethyl-6H-thieno[2,3-e][1,2,4]triaz...)
Affinity DataIC50: 96nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527553(US11186588, Example 8)
Affinity DataIC50: 104nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527575(US11186588, Example 38)
Affinity DataIC50: 106nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527609(US11186588, Example 82)
Affinity DataIC50: 135nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527561(US11186588, Example 18)
Affinity DataIC50: 144nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527571(US11186588, Example 31)
Affinity DataIC50: 150nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527565(US11186588, Example 23)
Affinity DataIC50: 158nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527555(US11186588, Example 10)
Affinity DataIC50: 192nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527585(US11186588, Example 49)
Affinity DataIC50: 197nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527558(US11186588, Example 13)
Affinity DataIC50: 233nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527601(US11186588, Example 73)
Affinity DataIC50: 246nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527587(US11186588, Example 51)
Affinity DataIC50: 265nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527570(US11186588, Example 29)
Affinity DataIC50: 265nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527559(US11186588, Example 14)
Affinity DataIC50: 276nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527618(US11186588, Example 103 | US11186588, Example 99)
Affinity DataIC50: 289nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527556(US11186588, Example 11)
Affinity DataIC50: 291nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527584(US11186588, Example 48)
Affinity DataIC50: 297nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527615(Synthesis of | US11186588, Example 90)
Affinity DataIC50: 298nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527586(US11186588, Example 50)
Affinity DataIC50: 355nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527595(US11186588, Example 61)
Affinity DataIC50: 377nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527574(US11186588, Example 36)
Affinity DataIC50: 401nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527581(US11186588, Example 45)
Affinity DataIC50: 429nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527583(US11186588, Example 47)
Affinity DataIC50: 554nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527614(US11186588, Example 89)
Affinity DataIC50: 556nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527592(US11186588, Example 57)
Affinity DataIC50: 558nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527573(US11186588, Example 34)
Affinity DataIC50: 612nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527576(US11186588, Example 39)
Affinity DataIC50: 620nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527613(US11186588, Example 88)
Affinity DataIC50: 631nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527600(US11186588, Example 71)
Affinity DataIC50: 634nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527582(US11186588, Example 46)
Affinity DataIC50: 683nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527577(US11186588, Example 40)
Affinity DataIC50: 699nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527593(64 | US11186588, Example 58)
Affinity DataIC50: 728nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527552(US11186588, Example 7)
Affinity DataIC50: 735nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527606(US11186588, Example 79)
Affinity DataIC50: 742nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527598(US11186588, Example 65)
Affinity DataIC50: 896nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetNuclear factor NF-kappa-B p105 subunit(Human)
Ayumi Pharmaceutical

US Patent
LigandPNGBDBM527591(US11186588, Example 56)
Affinity DataIC50: 942nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: